Related Experiment Video
Updated: Aug 8, 2026
08:30
Microinjectrode System for Combined Drug Infusion and Electrophysiology
Published on: November 13, 2019
Engineering integrated drug-device systems for autonomous administration, programmable release, and therapeutic
Ningye Ma1, Yuan Wang2, Yitong Wang3
1Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Summary
Integrated drug-device systems (IDDSs) offer autonomous therapeutic control, moving precise drug delivery beyond clinical settings. These systems engineer mechanical autonomy, programmable release, and feedback integration for decentralized care.
Area of Science:
- Drug delivery systems
- Biomedical engineering
- Therapeutic technologies
Background:
- Advanced therapeutics demand precise control over drug delivery, often limited to professional settings.
- Translating complex therapies to home-based or decentralized care faces delivery-science challenges, not just adherence issues.
Purpose of the Study:
- To define integrated drug-device systems (IDDSs) as autonomous therapeutic architectures.
- To reframe IDDS technologies around key engineering pillars for decentralized therapeutic control.
Main Methods:
- Reviewing and organizing IDDS technologies based on mechanical autonomy, programmable release, and monitoring-decision integration.
- Proposing a maturity-grading model and an Available-Accessible-Controllable (AAC) framework for IDDS evaluation.
Main Results:
- IDDSs embed professional delivery logic into system-controlled platforms.
- Engineering pillars enable autonomous administration, programmable release, and feedback regulation.
- The proposed frameworks evaluate IDDS feasibility for clinical usability and accessibility.
Conclusions:
- IDDSs decouple therapeutic precision from manual operation, enabling robust control in decentralized environments.
- This review provides a roadmap for next-generation drug-device systems.
- IDDSs are crucial for advancing chronic, home-based, or decentralized therapeutic care.
Related Concept Videos
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...